Inflated type I error with fixed widened limits? [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2020-11-25 16:07 (2042 d 03:53 ago) – Posting: # 22085
Views: 17,330

Dear Helmut,

❝ What happens if we pre-specify the widened acceptance range and discover in the study that CVwR ≤30? Assess the study for the conventional AR of 80.00–125.00%? IMHO, that means we have a data-driven decision – which might be false and result in an inflated type I error.


Correct.

❝ I performed simulations acc. to my understanding of the GL:

[image]


❝ CVwR = CVwT = 30%, balanced 4-period 2-sequence full replicate design (TRTR|RTRT), n = 40 (81% power for θ0 = 0.90), 106 studies with θ0 = 1.25: ~20.6% passed…


Confirmed! At least in magnitude.
My result: 20.46% passed.
Quick and dirty captured code from power.scABEL.sds.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
250 visitors (0 registered, 250 guests [including 21 identified bots]).
Forum time: 21:00 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5